Literature DB >> 21160805

Gastric cancer, Helicobacter pylori infection and other risk factors.

Lorenzo Fuccio1, Leonardo Henry Eusebi, Franco Bazzoli.   

Abstract

Gastric cancer incidence is declining. However, it is too early to consider this neoplastic disease as rare and the worldwide mortality rate still remains high. Several risk factors have been identified for non-cardia gastric cancer and primary prevention is feasible since most of the risk factors can be removed. Helicobacter pylori eradication treatment reduces but does not abolish gastric cancer risk. Indeed, gastric cancer is a multifactorial disease and removing one factor does not therefore prevent all cases. Endoscopic surveillance is still needed, especially in subjects at higher risk. The definition of high-risk patients will be the future challenge as well as identifying the best surveillance strategy for such patients.

Entities:  

Keywords:  Diet; Eradication treatment; Gastric cancer; Helicobacter pylori

Year:  2010        PMID: 21160805      PMCID: PMC2999139          DOI: 10.4251/wjgo.v2.i9.342

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  62 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer.

Authors:  Lorenzo Fuccio; Leonardo Henry Eusebi; Rocco Maurizio Zagari; Franco Bazzoli
Journal:  Am J Gastroenterol       Date:  2009-12       Impact factor: 10.864

3.  Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.

Authors:  Steven C Cunningham; Farin Kamangar; Min P Kim; Sommer Hammoud; Raqeeb Haque; Anirban Maitra; Elizabeth Montgomery; Richard E Heitmiller; Michael A Choti; Keith D Lillemoe; John L Cameron; Charles J Yeo; Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

4.  Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group.

Authors:  J V Joossens; M J Hill; P Elliott; R Stamler; E Lesaffre; A Dyer; R Nichols; H Kesteloot
Journal:  Int J Epidemiol       Date:  1996-06       Impact factor: 7.196

5.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

6.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

Review 7.  Cellular origin of gastric cancer.

Authors:  Sherif M Karam
Journal:  Ann N Y Acad Sci       Date:  2008-09       Impact factor: 5.691

Review 8.  Carcinogenesis of Helicobacter pylori.

Authors:  Pelayo Correa; Jeanmarie Houghton
Journal:  Gastroenterology       Date:  2007-08       Impact factor: 22.682

9.  Family history and risk of stomach cancer in Italy.

Authors:  D Palli; M Galli; N E Caporaso; F Cipriani; A Decarli; C Saieva; J F Fraumeni; E Buiatti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Jan-Feb       Impact factor: 4.254

10.  Family history and the risk of gastric cancer.

Authors:  M Yaghoobi; R Bijarchi; S A Narod
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more
  26 in total

1.  The relationship between gastric cancer and Helicobacter pylori in formaldehyde fixed paraffin embedded gastric tissues of gastric cancer patients-scorpion real-time PCR assay findings.

Authors:  Taghi Naserpour Farivar; Pouran Johari; Reza Najafipour; Amir Farzam; Neda Nasirian; Fatemeh HajManouchehri; Hassan Jahani Hashemi; Akram Azimi; Mohammad Bahrami
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

2.  Sugar-Modified Analogs of Auranofin Are Potent Inhibitors of the Gastric Pathogen Helicobacter pylori.

Authors:  Tessa D Epstein; Bin Wu; Karen D Moulton; Mingdi Yan; Danielle H Dube
Journal:  ACS Infect Dis       Date:  2019-09-09       Impact factor: 5.084

3.  Role of Sonic Hedgehog signaling during progression from inflammation to cancer in the stomach.

Authors:  Alexander E Sherman; Yana Zavros
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

4.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

5.  Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression.

Authors:  Solbi Kim; Ji-Eun Kim; Nayoung Kim; Mina Joo; Myung-Won Lee; Heung Jin Jeon; Hyewon Ryu; Ik-Chan Song; Gyu-Yong Song; Hyo Jin Lee
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 6.  Helicobacter pylori eradication and reflux disease onset: did gastric acid get "crazy"?

Authors:  Angelo Zullo; Cesare Hassan; Alessandro Repici; Vincenzo Bruzzese
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

7.  Opium: an emerging risk factor for gastric adenocarcinoma.

Authors:  Ramin Shakeri; Reza Malekzadeh; Arash Etemadi; Dariush Nasrollahzadeh; Karim Aghcheli; Masoud Sotoudeh; Farhad Islami; Akram Pourshams; Michael Pawlita; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Farin Kamangar
Journal:  Int J Cancer       Date:  2013-02-13       Impact factor: 7.396

8.  Helicobacter pylori therapy: Present and future.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Cesare Hassan; Angelo Zullo
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

Review 9.  Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.

Authors:  Ankur Singh; Ilana Brito; Jan Lammerding
Journal:  Trends Cancer       Date:  2018-03-10

10.  Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders.

Authors:  Farzam Vaziri; Shahin Najar Peerayeh; Masoud Alebouyeh; Tabassom Mirzaei; Yoshio Yamaoka; Mahsa Molaei; Nader Maghsoudi; Mohammad Reza Zali
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.